STOCKHOLDERS’ EQUITY - Stock Option Activity (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Sep. 30, 2023
Number of Shares
Outstanding at beginning of period (in shares)	651,269
Granted (in shares)	0	0
Exercised (in shares)	(96,634)
Canceled (in shares)	0
Outstanding at end of period (in shares)	554,635		651,269
Weighted-Average Exercise Price (in dollars per share)
Outstanding at beginning of period (in dollars per share)	$ 7.37
Granted (in dollars per share)	0
Exercised (in dollars per share)	8.85
Canceled (in dollars per share)	0
Outstanding at end of period (in dollars per share)	$ 7.11		$ 7.37
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]
Vested and Expected to Vest (in shares)	554,635
Exercisable (in shares)	554,635
Vested and Expected to Vest, Weighted-Average Exercise Price (in dollars per share)	$ 7.11
Exercisable, Weighted-Average Exercise Price (in dollars per share)	$ 7.11
Outstanding, Weighted-Average Remaining Contractual Terms (in Years)	4 years		3 years 7 months 6 days
Vested and Expected to Vest, Weighted-Average Remaining Contractual Term (in Years)	4 years
Exercisable, Weighted-Average Remaining Contractual Term (in Years)	4 years
Outstanding, Aggregate Intrinsic Value	$ 3,291		$ 2,185
Exercised, aggregate intrinsic value	169
Vested and Expected to Vest, Aggregate Intrinsic Value	3,291
Exercisable, Aggregate Intrinsic Value	$ 3,291